- RBC Capital analyst Ken Herbert lowered the price target on Boeing Co (NYSE:BA) to $200 (39% upside) from $220 while maintaining the Outperform rating on the shares.
- The analyst states that the strong June deliveries support confidence into 2H22; the focus remains on the MAX production and delivery outlook, the 787 resumptions of deliveries, and the 2022 FCF guide.
- Herbert mentions that expectations around the Farnborough airshow are low, which could provide a positive catalyst.
- Also Read: Airbus, Delta Explore Expanding A220 Jet Order: Reuters
- The analyst continues to like the stock near-term on potential catalysts and continues to model positive 2022 FCF.
- Meanwhile, Herbert lowered the price target, citing lower multiples reflecting long-term headwinds.
- Herbert sees certification of the MAX-10 by December as increasingly to be at risk.
- Price Action: BA shares are trading higher by 0.03% at $143.99 on the last check Thursday.
- Photo Via Wikimedia
Phio Pharmaceuticals Announces $2M Registered Direct Offering Of 353,983 Shares Of Common Stock At Price Of $5.65/Share At-The-Market Under Nasdaq Rules
Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today
